Date: May 26, 2021
Location: Virtual Conference
Head of R&D, Bioconjugates, Catalent
Session Title: Catalent’s SMARTag® Technology: Precision-Based ADC Design
Session Time: 10:55AM – 11:05AM PT
Abstract: Catalent’s SMARTag® technology platform offers ADC and biologics developers a one-step toolkit to develop optimized ADCs and bioconjugates. The SMARTag® technology enables site-specific, controlled drug-protein conjugation, and uses only naturally occurring modifications to proteins requiring minimal cell-line engineering.